Switzerland

Location
Mentions
259
Relationships
1
Events
0
Documents
117
Also known as:
Basel, Switzerland Zermatt, Switzerland Zurich, Switzerland Verbier, Switzerland Suisse (Switzerland) Le Route de la Ballaz, 1008 Jouxtens-Mezery, Switzerland La Gordanne, 1166 Pe, Switzerland

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
1 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Bodmer
Citizenship
1
1
View
No events found for this entity.

HOUSE_OVERSIGHT_025264.jpg

A UBS financial research slide dated October 24, 2012, analyzing Swiss equities with a "neutral" preference. The document outlines positive and negative economic scenarios, provides 6-month tactical and 1-2 year strategic recommendations, and lists upcoming economic indicators and corporate news dates. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.

Financial research report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_025260.jpg

This document is page 13 of a UBS financial presentation titled 'Equities overview,' produced as part of the House Oversight Committee's investigation (Bates stamp HOUSE_OVERSIGHT_025260). It details UBS's global equity market strategies, expressing preferences for US and Emerging Market equities while maintaining neutral or negative stances on Eurozone, Canadian, and Australian markets. The document lists Markus Irngartinger and Carsten Schlufter as contacts and appears to date from late 2012 based on forward-looking references to 2013.

Financial report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_025254.jpg

This document is a UBS 'Global economic outlook' summary dated October 24, 2012, analyzing global economic prospects, risks, and key upcoming dates for late 2012 and early 2013. It provides statistical forecasts for GDP growth and inflation across major global economies and outlines positive and negative economic scenarios, focusing heavily on US recovery, the Eurozone crisis, and the Chinese economy. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production to the US House Oversight Committee.

Financial report / economic outlook
2025-11-19

HOUSE_OVERSIGHT_025252.jpg

This document is a page from a UBS financial report dated October 25, 2012, detailing recommended tactical asset allocations and currency allocations. It visualizes deviations from benchmarks for various asset classes (Equities, Bonds, Commodities) and currencies, suggesting specific investment strategies (e.g., underweighting government bonds, overweighting high yield bonds). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely obtained as evidence during a Congressional investigation, presumably related to financial oversight involving Jeffrey Epstein's banking relationships.

Financial report / investment strategy document
2025-11-19

HOUSE_OVERSIGHT_024937.jpg

This document appears to be a page from a transcript of an interview between journalist Matt Slater (The National Abu Dhabi Media Company) and a high-ranking UAE official. The text covers the historical union of the UAE, the centralization of health and education policies versus decentralized implementation, and the role and evolution of the Federal National Council (FNC). The document bears a House Oversight Bates stamp.

Interview transcript / q&a document
2025-11-19

HOUSE_OVERSIGHT_024899.jpg

This page from a Cowen market research report, dated February 25, 2019, analyzes the regulatory environment and market trends for CBD and hemp products in Switzerland and France. It details Swiss regulations regarding cosmetic products and recent corporate consolidations (LGC Capital, Wayland, Creso Pharma), while noting France's status as a leading hemp cultivator despite strict government crackdowns on retail CBD sales. The document bears a House Oversight Committee stamp, suggesting it was part of a congressional document production.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024898.jpg

This document is page 82 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the cannabis and hemp markets in Italy and Switzerland. It details regulatory environments, specifically the 'cannabis light' market in Italy and medical/tobacco substitute regulations in Switzerland, while listing various corporate investments and acquisitions (Wayland, Canopy, CROP). The document bears a 'HOUSE_OVERSIGHT_024898' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely included in a larger batch of financial records.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024896.jpg

This document is page 80 of a financial research report produced by Cowen, dated February 25, 2019, analyzing the regulatory landscape for medical cannabis and CBD in Europe. It details the European Parliament's non-binding resolution to harmonize cannabis policies, compares THC limits between the EU (0.2%) and North America (0.3%), and discusses the classification of CBD within the 'Novel Food Catalogue.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.

Financial research report / industry analysis
2025-11-19

HOUSE_OVERSIGHT_024821.jpg

This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024750.jpg

This document is page 114 from an Ackrell Capital 'Cannabis Investment Report' dated December 2017. It presents a data table titled 'Emerging and Anticipated International Legal Cannabis Markets,' detailing GDP rank, population, projected spending, and potential market value for various countries. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024750,' indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial institutions connected to Epstein, though the content itself is strictly market analysis.

Investment report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024728.jpg

This document is page 92 of a 'Cannabis Investment Report' dated December 2017 by Ackrell Capital, LLC. It features a world map and lists categorizing countries by their cannabis laws (Medical, Recreational, or State/Federal Conflict). The document bears a 'HOUSE_OVERSIGHT_024728' Bates stamp, indicating it was part of a document production for a congressional investigation, likely related to financial oversight.

Investment report page
2025-11-19

HOUSE_OVERSIGHT_024215.jpg

This is page 14 of a confidential 'Global Utility White Paper' produced by Electron Capital Partners, LLC, specifically marked for the exclusive use of Jeffrey Epstein. The document analyzes investment opportunities in the global utility sector circa 2013, highlighting rebounding capital expenditure in Europe and Asia, the impact of the shale gas boom, and 'alpha opportunities' following a period of market underperformance. It lists specific utility companies and infrastructure projects across the US, Europe, and China as potential beneficiaries.

Financial white paper / investment research page
2025-11-19

HOUSE_OVERSIGHT_024201.jpg

This document is page 8 of a J.P. Morgan 'Eye on the Market' report dated October 22, 2012, containing standard legal disclaimers and regulatory disclosures for various international jurisdictions including the UK, Hong Kong, Singapore, and Latin America. It identifies Michael Cembalest as the source of opinions within the report and outlines limitations regarding tax advice and FDIC insurance. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, likely related to the Epstein inquiry involving J.P. Morgan.

Financial report disclaimer / regulatory disclosure (house oversight production)
2025-11-19

HOUSE_OVERSIGHT_024177.jpg

This document is a contact list for the UBS Global Investment Office, page 42 of a larger production (marked HOUSE_OVERSIGHT_024177). It lists names, titles, and UBS email addresses for senior leadership including Alexander Friedman (Global CIO) and Mark Haefele (Global Head of Investment), as well as staff in Asset Allocation and Regional CIOs for Europe, Asia-Pacific, Emerging Markets, and Switzerland. The document appears to be part of discovery materials provided to the House Oversight Committee.

Contact list / corporate directory
2025-11-19

HOUSE_OVERSIGHT_024160.jpg

This document is a UBS financial market report slide titled 'European rates' dated approximately June 29, 2012. It provides analysis on German Bund yields, the Eurozone debt crisis, and central bank actions (ECB, BoE, Fed), offering tactical and strategic investment recommendations. While the document does not mention Jeffrey Epstein directly, it bears the Bates stamp 'HOUSE_OVERSIGHT_024160', indicating it was part of evidence gathered by the House Oversight Committee, likely related to investigations into financial institutions.

Financial market report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_024158.jpg

This document is page 23 of a UBS financial report titled 'Bonds overview,' dated June 19, 2012. It provides market analysis on government, corporate, and emerging market bonds, discussing factors like the Greek elections, Federal Reserve policy (Operation Twist), and bond yield projections. The document bears a 'HOUSE_OVERSIGHT_024158' Bates stamp, indicating it was part of a document production for a congressional oversight committee, likely related to an investigation involving financial records.

Financial report / investment analysis
2025-11-19

HOUSE_OVERSIGHT_024152.jpg

This document is a UBS financial analysis slide regarding Swiss equities from June 2012, marked with a House Oversight Bates stamp (HOUSE_OVERSIGHT_024152). It provides a market outlook, suggesting an 'underweight' preference, details positive and negative economic scenarios, and lists upcoming corporate earnings announcements for major Swiss companies. The document lists Stefan Meyer as the contact point for further information.

Financial analysis report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_024148.jpg

This document is a UBS financial research slide dated June 28, 2012, providing an overview of global equity markets and sectors. It details UBS's investment stances, including a preference for US and UK markets while maintaining negative views on the Eurozone and cautious views on Australia. The document includes contact information for UBS specialists Markus Irngartinger and Carsten Schlufter and bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, likely related to financial probes involving banks.

Financial research report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_024140.jpg

This document is a slide from a UBS financial presentation titled 'Reference portfolio.' It displays bar charts detailing tactical asset allocation deviations (equities, bonds, commodities) and currency allocations, comparing 'new' versus 'old' positions. The document bears the Bates stamp HOUSE_OVERSIGHT_024140, indicating it is part of the House Oversight Committee's investigation records.

Financial report / investment portfolio slide
2025-11-19

HOUSE_OVERSIGHT_024115.jpg

This document is page 104 of a confidential offering memorandum (Control Number 257) produced to the House Oversight Committee. It details legal restrictions and disclaimers regarding the sale of interests in 'the Fund' in Saudi Arabia, South Africa, South Korea, Spain, Sweden, and Switzerland, citing specific local financial regulations (such as CISA in Switzerland and the Financial Investment Services and Capital Markets Act in South Korea). It specifies that the fund is generally unregistered in these jurisdictions and available only to qualified/professional investors.

Legal/financial document (private placement memorandum/offering memorandum)
2025-11-19

HOUSE_OVERSIGHT_025697.jpg

This document is a standard legal disclaimer page (page 34) from a Goldman Sachs Investment Management Division presentation or report. It outlines the trademark and licensing details for various market indices (S&P, Dow Jones, MSCI, Russell, Tokyo Stock Exchange, and EURO Stoxx) referenced in the broader document. While it contains no specific information about Jeffrey Epstein, the Bates stamp 'HOUSE_OVERSIGHT_025697' indicates this page was part of a larger document production submitted to the House Oversight Committee, likely during an investigation involving financial records held by Goldman Sachs.

Legal disclaimer / financial report page
2025-11-19

HOUSE_OVERSIGHT_025685.jpg

This document is a slide from a Goldman Sachs Investment Management Division presentation dated around July 2017. It analyzes the legal and regulatory status of cryptocurrencies across various nations (Switzerland, Singapore, Japan, UK, US, Russia, China). The document bears a Bates stamp (HOUSE_OVERSIGHT_025685), indicating it was produced as part of a US House Oversight Committee investigation, likely related to financial practices, though no specific individuals (like Epstein) are named on this specific page.

Presentation slide / financial report
2025-11-19

HOUSE_OVERSIGHT_014020.jpg

The document appears to be a page from a collection of testimonials or a book appendix (likely related to Tim Ferriss's 'The 4-Hour Workweek') included in a House Oversight Committee file (ID: 014020). It contains two success stories: one from I. Barron regarding personal freedom and immigrant success, and a longer letter from photographer Mark Cafiero detailing how he automated his business to travel to Switzerland and Italy. There is no direct textual mention of Jeffrey Epstein or his associates in the content itself; the connection is likely solely through the provenance of the document dump.

Testimonial letter / book excerpt (evidence file)
2025-11-19

HOUSE_OVERSIGHT_021072.jpg

This document contains two statistical tables from the 'USA Inc.' report produced by KPCB (Kleiner Perkins), likely part of a House Oversight Committee investigation based on the footer stamp. The first table ranks countries 51-75 by Net Debt as a percentage of GDP for 2009, showing China at rank 71. The second table ranks OECD countries by Gross Debt as a percentage of GDP for 2009, listing Japan as rank 1 (193%) and the USA as rank 9 (83%).

Financial report / statistical appendix
2025-11-19

HOUSE_OVERSIGHT_021049.jpg

This document consists of two slides from a KPCB presentation titled 'USA Inc. | Consequences of Inaction' (likely part of the Mary Meeker 'USA Inc.' series). The slides analyze the fiscal health of the United States compared to global peers, focusing on national debt, GDP ratios, and investor perspectives on US bonds. The document bears a 'HOUSE_OVERSIGHT_021049' Bates stamp, indicating it was part of a document production for a congressional investigation.

Presentation slides / financial report
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity